Peyer James bought SNSE
December 9, 2025 · Form 4 insider transaction
Peyer James bought 395 shares of SNSE at $6.40 per share, a transaction worth $2.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
395
Price
$6.40
Total value
$2.5K
InsiderPeyer James
Role10% owner
CompanySNSE
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 9, 2025
Filing dateDecember 10, 2025
Shares owned after155,983
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.